Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis

A. Khan (Chilly-Mazarin, France), I. Gouia (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America), B. Ortiz (Tarrytown, United States of America), R. Johnson (Bridgewater, United States of America), J. Siddall (Bollington, United Kingdom), M. Small (Bollington, United Kingdom)

Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Session: Management of allergy, asthma and COPD
Session type: E-poster session
Number: 232
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Khan (Chilly-Mazarin, France), I. Gouia (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America), B. Ortiz (Tarrytown, United States of America), R. Johnson (Bridgewater, United States of America), J. Siddall (Bollington, United Kingdom), M. Small (Bollington, United Kingdom). Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis. 232

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: